Search Results - "de Feijter, M."

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial by van Dijk, Nick, Gil-Jimenez, Alberto, Silina, Karina, Hendricksen, Kees, Smit, Laura A., de Feijter, Jeantine M., van Montfoort, Maurits L., van Rooijen, Charlotte, Peters, Dennis, Broeks, Annegien, van der Poel, Henk G., Bruining, Annemarie, Lubeck, Yoni, Sikorska, Karolina, Boellaard, Thierry N., Kvistborg, Pia, Vis, Daniel J., Hooijberg, Erik, Schumacher, Ton N., van den Broek, Maries, Wessels, Lodewyk F. A., Blank, Christian U., van Rhijn, Bas W., van der Heijden, Michiel S.

“…Preoperative immunotherapy with anti-PD1 plus anti-CTLA4 antibodies has shown remarkable pathological responses in melanoma 1 and colorectal cancer 2 . In…”
Get full text

A comprehensive overview of medical error in hospitals using incident-reporting systems, patient complaints and chart review of inpatient deaths by de Feijter, Jeantine M, de Grave, Willem S, Muijtjens, Arno M, Scherpbier, Albert J J A, Koopmans, Richard P

“…Incident reporting systems (IRS) are used to identify medical errors in order to learn from mistakes and improve patient safety in hospitals. However, IRS…”
Get full text

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice by de Ruiter, Ben-Max, van de Kamp, Maaike W., van Steenbergen, Jonah P.Z., Franckena, Martine, Boormans, Joost L., de Feijter, Jeantine M., Bins, Adriaan D., Hulshof, Maarten C.C.M., de Reijke, Theo M., Schaake, Eva, Oddens, Jorg R.

“…Chemoradiotherapy is a safe and effective treatment option for a wide range of muscle-invasive bladder carcinoma patients with 2-yr locoregional…”
Get full text

Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands by van Bergen, Jan E A M, Fennema, Johannes S A, van den Broek, Ingrid V F, Brouwers, Elfi E H G, de Feijter, Eva M, Hoebe, Christian J P A, Koekenbier, Rik H, de Coul, Eline L M Op, van Ravesteijn, Sander M, Götz, Hannelore M

“…Implementing Chlamydia trachomatis screening in the Netherlands has been a point of debate for several years. The National Health Council advised against…”
Get full text

Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis by van den Broek, Ingrid V F, Hoebe, Christian J P A, van Bergen, Jan E A M, Brouwers, Elfi E H G, de Feijter, Eva M, Fennema, Johannes S A, Götz, Hannelore M, Koekenbier, Rik H, van Ravesteijn, Sander M, de Coul, Eline L M Op

“…A selective, systematic, Internet-based, Chlamydia Screening Implementation for 16 to 29-year-old residents started in three regions in the Netherlands in…”
Get full text

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial by de Vries, Hielke M, Rafael, Tynisha S, Gil-Jimenez, Alberto, de Feijter, Jeantine M, Bekers, Elise, van der Laan, Elsbeth, Lopez-Yurda, Marta, Hooijberg, Erik, Broeks, Annegien, Peters, Dennis, Seignette, Iris M, Pos, Floris J, Horenblas, Simon, van Rhijn, Bas W G, Jordanova, Ekaterina S, Brouwer, Oscar R, Schaake, Eva, van der Heijden, Michiel S

“…Patients with advanced penile squamous cell carcinoma have a poor prognosis (21% 2-year overall survival [OS] from diagnosis). We assessed the activity of…”
Get full text

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial by van Dorp, Jeroen, Pipinikas, Christodoulos, Suelmann, Britt B. M., Mehra, Niven, van Dijk, Nick, Marsico, Giovanni, van Montfoort, Maurits L., Hackinger, Sophie, Braaf, Linde M., Amarante, Tauanne, van Steenis, Charlaine, McLay, Kirsten, Daletzakis, Antonios, van den Broek, Daan, van de Kamp, Maaike W., Hendricksen, Kees, de Feijter, Jeantine M., Boellaard, Thierry N., Meijer, Richard P., van der Heijden, Antoine G., Rosenfeld, Nitzan, van Rhijn, Bas W. G., Jones, Greg, van der Heijden, Michiel S.

“…Cohort 1 of the phase 1B NABUCCO trial showed high pathological complete response (pCR) rates with preoperative ipilimumab plus nivolumab in stage III…”
Get full text

Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone Acetate by Bruin, Maaike A. C., Mohmaed Ali, Ma Ida, van Nuland, Merel, Jacobs, Bart A. W., Lucas, Luc, Dezentje, Vincent O., de Feijter, Jeantine M., Rosing, Hilde, Bergman, Andries M., Beijnen, Jos H., Huitema, Alwin D. R.

“…Background Abiraterone acetate is an irreversible 17α-hydroxylase/C17, 20-lyase (CYP17) inhibitor approved for the treatment of metastatic castration-resistant…”
Get full text

Peritoneal Metastases From Prostate Carcinoma Treated With 177 Lu-PSMA-I&T by van Golen, Larissa W., Seijkens, Tom T.P., de Feijter, Jeantine M., Vogel, Wouter

“…A 71-year-old man was referred for 177 Lu-PSMA therapy. He had metastatic castration-resistant prostate cancer, progressive on several treatment lines, with…”
Get full text

Concomitant intake of abiraterone acetate and food to increase pharmacokinetic exposure: real life data from a therapeutic drug monitoring programme by Groenland, Stefanie L., van Nuland, Merel, Bergman, Andries M., de Feijter, Jeantine M., Dezentje, Vincent O., Rosing, Hilde, Beijnen, Jos H., Huitema, Alwin D.R., Steeghs, Neeltje

“…Abiraterone acetate is approved for the treatment of metastatic prostate cancer. At the currently used fixed dose of 1000 mg once daily in modified fasting…”
Get full text

Survival after neoadjuvant/induction combination immunotherapy vs combination platinum‐based chemotherapy for locally advanced (Stage III) urothelial cancer by Einerhand, Sarah M. H., Dijk, Nick, Dorp, Jeroen, Feijter, Jeantine M., Montfoort, Maurits L., Kamp, Maaike W., Schaake, Eva E., Boellaard, Thierry N., Hendricksen, Kees, Heijden, Michiel S., Rhijn, Bas W. G.

“…Despite treatment with cisplatin‐based chemotherapy and surgical resection, clinical outcomes of patients with locally advanced urothelial carcinoma (UC)…”
Get full text

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial by van Dorp, Jeroen, Pipinikas, Christodoulos, Suelmann, Britt B. M., Mehra, Niven, van Dijk, Nick, Marsico, Giovanni, van Montfoort, Maurits L., Hackinger, Sophie, Braaf, Linde M., Amarante, Tauanne, van Steenis, Charlaine, McLay, Kirsten, Daletzakis, Antonios, van den Broek, Daan, van de Kamp, Maaike W., Hendricksen, Kees, de Feijter, Jeantine M., Boellaard, Thierry N., Meijer, Richard P., van der Heijden, Antoine G., Rosenfeld, Nitzan, van Rhijn, Bas W. G., Jones, Greg, van der Heijden, Michiel S.

Get full text

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy by van der Zande, K., Tutuhatunewa-Louhanepessy, R.D., Hamberg, P., Ras, S., de Feijter, J.M., Dezentjé, V.O., Broeks, A., Cornelissen, S., Beeker, A., van der Noort, V., Zwart, W., Bergman, A.M.

“…•Innate or acquired resistance to cabazitaxel in mCRPC patients is a common event.•Addition of carboplatin in these cases, results in a secondary…”
Get full text

Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223 by Badrising, Sushil K., Louhanepessy, Rebecca D., van der Noort, Vincent, Kieffer, Jacobien, Coenen, Jules L. L. M., Hamberg, Paul, Beeker, Aart, Wagenaar, Nils, Lam, Marnix, Celik, Filiz, Loosveld, Olaf J. L., Oostdijk, Ad, Zuetenhorst, Hanneke, de Feijter, Jeantine M., Dezentjé, Vincent O., Ras-van Spijk, Suzan, Vegt, Erik, Haanen, John B., van de Poll-Franse, Lonneke V., Zwart, Wilbert, Bergman, Andries M.

“…Background Radium-223 (Ra-223), an alpha-emitting radiopharmaceutical, established an improved overall survival and health-related quality of life (HRQoL) in…”
Get full text

A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer by van Dorp, Jeroen, van Montfoort, Maurits L., van Dijk, Nick, Hofland, Ingrid, de Feijter, Jeantine M., Bergman, Andries M., Hendricksen, Kees, van der Poel, Henk G., van Rhijn, Bas W.G., van der Heijden, Michiel S.

“…-Incidental prostate cancer was found in cystoprostatectomy specimens in 9 out of 16 patients treated in the NABUCCO trial.-This was not statistically…”
Get full text

Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure by Feldman, E., Pos, F.J., Smeenk, R.J., van der Poel, H., van Leeuwen, P., de Feijter, J.M., Hulshof, M., Budiharto, T., Hermens, R., de Ligt, K.M., Walraven, I.

“…Clinician-based reporting of adverse events leads to underreporting and underestimation of the impact of adverse events on prostate cancer patients. Therefore,…”
Get full text

Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer by de Vries, Hielke M., Ottenhof, Sarah R., Rafael, Tynisha S., van Werkhoven, Erik, Pos, Floris J., van Rhijn, Bas W.G., Moonen, Luc M.F., Graafland, Niels, de Feijter, Jeantine M., Schaake, Eva E., Horenblas, Simon, Brouwer, Oscar R.

“…In penile cancer patients undergoing various treatments on their pelvis, there is a strong tendency for recurrence and systemic spread. Despite the treatments,…”
Get full text

Students’ perceptions of patient safety during the transition from undergraduate to postgraduate training: an activity theory analysis by de Feijter, Jeantine M., de Grave, Willem S., Dornan, Tim, Koopmans, Richard P., Scherpbier, Albert J. J. A.

“…Evidence that medical error can cause harm to patients has raised the attention of the health care community towards patient safety and influenced how and what…”
Get full text

Reflective learning in a patient safety course for final-year medical students by de Feijter, Jeantine M., de Grave, Willem S., Hopmans, Esther M., Koopmans, Richard P., Scherpbier, Albert J.J.A.

“…Background: Patient safety has become an important topic over the last decade and has also been increasingly implemented in the undergraduate curriculum…”
Get full text

Informal learning from error in hospitals: what do we learn, how do we learn and how can informal learning be enhanced? A narrative review by de Feijter, Jeantine M., de Grave, Willem S., Koopmans, Richard P., Scherpbier, Albert J. J. A.

“…Learning from error is not just an individual endeavour. Organisations also learn from error. Hospitals provide many learning opportunities, which can be…”
Get full text